Re: A Placebo-Controlled Study Investigating the Efficacy and Safety of the Phosphodiesterase Type 5 Inhibitor UK-369,003 for the Treatment of Men With Lower Urinary Tract Symptoms Associated With Clinical Benign Prostatic Hyperplasia

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Controlled Study ◽

Efficacy And Safety ◽

Urinary Tract Symptoms ◽

Phosphodiesterase Type ◽

A placebo-controlled study investigating the efficacy and safety of the phosphodiesterase type 5 inhibitor UK-369,003 for the treatment of men with lower urinary tract symptoms associated with clinical benign prostatic hyperplasia

BJU International ◽

10.1111/j.1464-410x.2010.09204.x ◽

2010 ◽

Vol 106 (5) ◽

pp. 674-680 ◽

Cited By ~ 35

Author(s):

Nihad A.M. Tamimi ◽

Ivan Mincik ◽

Scott Haughie ◽

Janice Lamb ◽

Anna Crossland ◽

...

Keyword(s):

Urinary Tract ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Controlled Study ◽

Efficacy And Safety ◽

Urinary Tract Symptoms ◽

Phosphodiesterase Type ◽

Role of Phosphodiesterase Type 5 Inhibitor on Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms

Korean Journal of Andrology ◽

10.5534/kja.2011.29.2.91 ◽

2011 ◽

Vol 29 (2) ◽

pp. 91 ◽

Cited By ~ 1

Author(s):

Sang Deuk Kim ◽

Jong Kwan Park

Keyword(s):

Urinary Tract ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Urinary Tract Symptoms ◽

Phosphodiesterase Type ◽

EFFECT OF PHOSPHODIESTERASE TYPE 5 INHIBITOR USE ON LOWER URINARY TRACT SYMPTOMS IN MEN WITH BENIGN PROSTATIC HYPERPLASIA (BPH): RESULTS FROM THE BPH REGISTRY

The Journal of Urology ◽

10.1016/s0022-5347(08)60408-5 ◽

2008 ◽

Vol 179 (4S) ◽

pp. 142-142

Author(s):

Raymond C Rosen ◽

John T Wei ◽

Martin Miner ◽

Claus G Roehrborn ◽

Allen D Seftel

Keyword(s):

Urinary Tract ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Urinary Tract Symptoms ◽

Phosphodiesterase Type ◽

Faculty Opinions recommendation of Efficacy and safety of the coadministration of tadalafil once daily with finasteride for 6 months in men with lower urinary tract symptoms and prostatic enlargement secondary to benign prostatic hyperplasia.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718133721.793486562 ◽

2013 ◽

Author(s):

Francisco Cruz

Keyword(s):

Urinary Tract ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Efficacy And Safety ◽

Once Daily ◽

Urinary Tract Symptoms ◽

Prostatic Enlargement ◽

Faculty Opinions recommendation of Minimally invasive prostate convective water vapor energy ablation: A multicenter, randomized, controlled study for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.725968810.793564004 ◽

2019 ◽

Author(s):

Alexis Te

Keyword(s):

Water Vapor ◽

Urinary Tract ◽

Minimally Invasive ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Controlled Study ◽

Randomized Controlled ◽

Urinary Tract Symptoms ◽

Efficacy and safety of tamsulosin hydrochloride compared to doxazosin in the treatment of Indonesian patients with lower urinary tract symptoms due to benign prostatic hyperplasia

International Journal of Urology ◽

10.1111/j.1442-2042.2006.01590.x ◽

2006 ◽

Vol 13 (11) ◽

pp. 1405-1409 ◽

Cited By ~ 7

Author(s):

DJOKO RAHARDJO ◽

DODDY M SOEBADI ◽

SUWANDI SUGANDI ◽

PONCO BIROWO ◽

WAHJOE DJATI ◽

...

Keyword(s):

Urinary Tract ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Efficacy And Safety ◽

Urinary Tract Symptoms ◽

The Use of Phosphodiesterase Type 5 Inhibitors in the Treatment of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia

Male Lower Urinary Tract Symptoms and Benign Prostatic Hyperplasia ◽

10.1002/9781118437889.ch10 ◽

2014 ◽

pp. 113-128

Author(s):

Casey Lythgoe ◽

Kevin T. McVary

Keyword(s):

Urinary Tract ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Phosphodiesterase Type 5 Inhibitors ◽

Urinary Tract Symptoms ◽

Phosphodiesterase Type ◽

Alpha-blockers with or without phosphodiesterase type 5 inhibitor for treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: a systematic review and meta-analysis

World Journal of Urology ◽

10.1007/s00345-018-2370-z ◽

2018 ◽

Vol 37 (1) ◽

pp. 143-153 ◽

Cited By ~ 7

Author(s):

Jianzhong Zhang ◽

Xiao Li ◽

Bin Yang ◽

Cheng Wu ◽

Yanghua Fan ◽

...

Keyword(s):

Systematic Review ◽

Urinary Tract ◽

Lower Urinary Tract ◽

Meta Analysis ◽

Prostatic Hyperplasia ◽

Alpha Blockers ◽

Urinary Tract Symptoms ◽

Phosphodiesterase Type ◽

Efficacy and safety of combined therapy with terazosin and tolteradine for patients with lower urinary tract symptoms associated with benign prostatic hyperplasia: a prospective study

Chinese Medical Journal ◽

10.1097/00029330-200703010-00004 ◽

2007 ◽

Vol 120 (5) ◽

pp. 370-374 ◽

Cited By ~ 37

Author(s):

Yong YANG ◽

Xiao-feng ZHAO ◽

Han-zhong LI ◽

Wei WANG ◽

Yong ZHANG ◽

...

Keyword(s):

Urinary Tract ◽

Prospective Study ◽

Lower Urinary Tract ◽

Combined Therapy ◽

Prostatic Hyperplasia ◽

Efficacy And Safety ◽

Urinary Tract Symptoms ◽

A Prospective Study ◽

Efficacy and Safety of Tamsulosin for Treating Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia: A Multicenter, Randomized, Controlled, Open-Label Non-Inferiority Study

Korean Journal of Urology ◽

10.4111/kju.2012.53.3.178 ◽

2012 ◽

Vol 53 (3) ◽

pp. 178 ◽

Cited By ~ 7

Author(s):

Hyo Serk Lee ◽

Sae Woong Kim ◽

Seung-June Oh ◽

Myung-Soo Choo ◽

Kyu-Sung Lee

Keyword(s):

Urinary Tract ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Efficacy And Safety ◽

Open Label ◽

Randomized Controlled ◽

Urinary Tract Symptoms ◽